Advertisement
Advertisement
MIRA
MIRA Pharmaceuticals, Inc. Common Stock
1.01
USDSponsored
-0.01
-0.49%
May 06, 11:21 UTC -4
Open
MIRA Earnings Reports
Positive Surprise Ratio
MIRA beat 5 of 8 last estimates.
63%
Next Report
Next Week
Date of Next Report
May 12, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q1 25 (Revenue/ EPS)
--
/--
MIRA Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On Mar 31, 2026, MIRA reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.04 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +11.08% price change (close before vs. close after earnings).
Looking ahead to Q1 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Royalty Pharma plc Class A Ordinary Shares
Report Date
May 06, 2026 For Q1 26
Estimate
$1.23
Actual
$1.30
Surprise
+5.11%
Bio-Techne Corp.
Report Date
May 06, 2026 For Q3 26
Estimate
$0.54
Actual
$0.53
Surprise
-3.34%
Alkermes Inc. plc
Report Date
May 05, 2026 For Q1 26
Estimate
-$0.57
Actual
-$0.40
Surprise
+30.87%
TG Therapeutics, Inc.
Report Date
May 06, 2026 For Q1 26
Estimate
$0.30
Actual
$0.17
Surprise
-43.97%
Recursion Pharmaceuticals, Inc. Class A Common Stock
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.27
Actual
-$0.22
Surprise
+20.55%
Novavax Inc
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.46%
EyePoint, Inc. Common Stock
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.81
Actual
-$0.99
Surprise
-21.68%
Geron Corp
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.02
Actual
-$0.01
Surprise
+52.61%
UroGen Pharma Ltd. Ordinary Shares
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.49
Actual
-$0.47
Surprise
+4.51%
Myriad Genetics Inc
Report Date
May 05, 2026 For Q1 26
Estimate
-$0.06
Actual
-$0.09
Surprise
-28.94%
FAQ
What were MIRA Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, MIRA Pharmaceuticals, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
How did the market react to MIRA Pharmaceuticals, Inc. Common Stock's Q4 2025 earnings?
The stock price moved up 11.08%, changed from $0.96 before the earnings release to $1.07 the day after.
When is MIRA Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for May 12, 2026.
What are the forecasts for MIRA Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on --
analysts, MIRA Pharmaceuticals, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement